DNA methylation in osteoarthritis

Current Genomics

Volumn 16, Issue 6, 2015, Pages 419-426

  den Hollander, Wouter ^a   Meulenbelt, Ingrid ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Articular cartilage; Data integration; DNA methylation; Osteoarthritis; Transcriptomics

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 5; THYROXINE DEIODINASE;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMEOBOX; HUMAN; OSTEOARTHRITIS; PHENOTYPE; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 84942086399     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202916666150817212711     Document Type: Article

References (69)

1. Bijlsma, J.W.; Berenbaum, F.; Lafeber, F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011, 377(9783), 2115-2126.
2. Woolf, A.D.; Erwin, J.; March, L. The need to address the burden of musculoskeletal conditions. Best. Pract. Res. Clin. Rheumatol., 2012, 26(2), 183-224.
3. Thysen, S.; Luyten, F.P.; Lories, R.J. Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability-induced osteoarthritis. Osteoarthritis. Cartilage, 2015, 23 (2), 275-279.
4. Cui, Z.; Xu, C.; Li, X.; Song, J.; Yu, B. Treatment with recombinant lubricin attenuates osteoarthritis by positive feedback loop between articular cartilage and subchondral bone in ovariectomized rats. Bone, 2015, 74C, 37-47.
5. Binks, D.A.; Gravallese, E.M.; Bergin, D.; Hodgson, R.J.; Tan, A. L.; Matzelle, M. M.; McGonagle, D.; Radjenovic, A. Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis. Ann. Rheum. Dis., 2015, 74(1), 196-203.
6. van Lent, P.L.; Blom, A.B.; Schelbergen, R.F.; Sloetjes, A.; Lafeber, F.P.; Lems, W.F.; Cats, H.; Vogl, T.; Roth, J.; van den Berg, W. B. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum., 2012, 64(5), 1466-1476.
7. Lories, R.J.; Corr, M.; Lane, N.E. To Wnt or not to Wnt: the bone and joint health dilemma. Nat. Rev. Rheumatol., 2013, 9(6), 328-339.
8. Ford, C.E.; Qian Ma, S.S.; Quadir, A.; Ward, R.L. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int. J. Cancer, 2013, 133(4), 779-787.
9. Hosseini, S.M.; Wu, Y.; Ito, K.; van Donkelaar, C.C. The importance of superficial collagen fibrils for the function of articular cartilage. Biomech. Model. Mechanobiol., 2014, 13(1), 41-51.
10. Lotz, M.; Loeser, R.F. Effects of aging on articular cartilage homeostasis. Bone, 2012, 51(2), 241-248.
11. Goldring, M.B.; Marcu, K.B. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol. Med., 2012, 18(2), 109-118.
12. Struglics, A.; Larsson, S.; Pratta, M.A.; Kumar, S.; Lark, M.W.; Lohmander, L.S. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase-and matrix metalloproteinasegenerated aggrecan fragments. Osteoarthritis. Cartilage, 2006, 14 (2), 101-113.
13. Roach, H.I.; Yamada, N.; Cheung, K.S.; Tilley, S.; Clarke, N.M.; Oreffo, R.O.; Kokubun, S.; Bronner, F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum., 2005, 52(10), 3110-3124.
14. Hashimoto, K.; Otero, M.; Imagawa, K.; de Andres, M.C.; Coico, J. M.; Roach, H.I.; Oreffo, R.O.; Marcu, K.B.; Goldring, M.B. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem., 2013, 288(14), 10061-10072.
15. Aigner, T.; Dudhia, J. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann. Rheum. Dis., 1997, 56 (5), 287-291.
16. Facchini, A.; Borzi, R. M.; Olivotto, E.; Platano, D.; Pagani, S.; Cetrullo, S.; Flamigni, F. Role of polyamines in hypertrophy and terminal differentiation of osteoarthritic chondrocytes. Amino. Acids 2012, 42 (2-3), 667-678.
17. Sun, M.M.; Beier, F. Chondrocyte hypertrophy in skeletal development, growth, and disease. Birth Defects Res. C. Embryo. Today, 2014, 102(1), 74-82.
18. Bantsimba-Malanda, C.; Cottet, J.; Netter, P.; Dumas, D.; Mainard, D.; Magdalou, J.; Vincourt, J. B. Chondrocalcin is internalized by chondrocytes and triggers cartilage destruction via an interleukin-1beta-dependent pathway. Matrix Biol., 2013, 32(7-8), 443-451.
19. van, C.A.; Blaney, D.E.; Garcia, D.V; van, G.E.; van den Berg, W.; Goumans, M.J.; Ten, D.P.; van der Kraan, P. The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFbeta1. Osteoarthritis. Cartilage., 2015, 23(6), 985-95.
20. Jaenisch, R.; Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet., 2003, 33 Suppl, 245-254.
21. Slieker, R.C.; Bos, S.D.; Goeman, J.J.; Bovee, J.V.; Talens, R.P.; van der Breggen, R.; Suchiman, H.E.; Lameijer, E.W.; Putter, H.; van den Akker, E.B.; Zhang, Y.; Jukema, J.W.; Slagboom, P.E.; Meulenbelt, I.; Heijmans, B.T. Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics. Chromatin., 2013, 6(1), 26.
22. Laurent, L.; Wong, E.; Li, G.; Huynh, T.; Tsirigos, A.; Ong, C.T.; Low, H.M.; Kin Sung, K.W.; Rigoutsos, I.; Loring, J.; Wei, C.L. Dynamic changes in the human methylome during differentiation. Genome Res., 2010, 20(3), 320-331.
23. Lister, R.; Pelizzola, M.; Dowen, R.H.; Hawkins, R.D.; Hon, G.; Tonti-Filippini, J.; Nery, J.R.; Lee, L.; Ye, Z.; Ngo, Q.M.; Edsall, L.; Antosiewicz-Bourget, J.; Stewart, R.; Ruotti, V.; Millar, A.H.; Thomson, J.A.; Ren, B.; Ecker, J. R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 2009, 462(7271), 315-322.
24. Gutierrez-Arcelus, M.; Lappalainen, T.; Montgomery, S.B.; Buil, A.; Ongen, H.; Yurovsky, A.; Bryois, J.; Giger, T.; Romano, L.; Planchon, A.; Falconnet, E.; Bielser, D.; Gagnebin, M.; Padioleau, I.; Borel, C.; Letourneau, A.; Makrythanasis, P.; Guipponi, M.; Gehrig, C.; Antonarakis, S.E.; Dermitzakis, E.T. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife, 2013, 2, e00523.
25. Ramos, Y.F.; den, H.W.; Bovee, J.V.; Bomer, N.; van der Breggen, R.; Lakenberg, N.; Keurentjes, J.C.; Goeman, J.J.; Slagboom, P.E.; Nelissen, R.G.; Bos, S.D.; Meulenbelt, I. Genes Involved in the Osteoarthritis Process Identified through Genome Wide Expression Analysis in Articular Cartilage; the RAAK Study. PLoS ONE, 2014, 9(7), e103056.
26. Wang, H.; Maurano, M.T.; Qu, H.; Varley, K.E.; Gertz, J.; Pauli, F.; Lee, K.; Canfield, T.; Weaver, M.; Sandstrom, R.; Thurman, R.E.; Kaul, R.; Myers, R.M.; Stamatoyannopoulos, J.A. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res., 2012, 22(9), 1680-1688.
27. Wagner, J.R.; Busche, S.; Ge, B.; Kwan, T.; Pastinen, T.; Blanchette, M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol., 2014, 15(2), R37.
28. Reynard, L.N.; Bui, C.; Canty-Laird, E.G.; Young, D.A.; Loughlin, J. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet., 2011, 20(17), 3450-3460.
29. Bomer, N.; den Hollander, W.; Ramos, Y.F. M.; Bos, S.D.; van der Breggen, R.; Lakenberg, N.; Pepers, B.A.; van Eeden, A.E.; Darvishan, A.; Tobi, E.W.; Duijnisveld, B.J.; van den Akker, E.B.; Heijmans, B.T.; van Roon-Mom, W.M.; Verbeek, F.J.; van Osch, G.J. V.M.; Nelissen, R.G.H.H.; Slagboom, P.E.; Meulenbelt, I. Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann. Rheum. Dis., 2014, 74(8), 1571-9.
30. Hashimoto, K.; Otero, M.; Imagawa, K.; de Andres, M.C.; Coico, J. M.; Roach, H.I.; Oreffo, R.O.; Marcu, K.B.; Goldring, M.B. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem., 2013, 288(14), 10061-10072.
31. Imagawa, K.; de Andres, M.C.; Hashimoto, K.; Itoi, E.; Otero, M.; Roach, H.I.; Goldring, M.B.; Oreffo, R.O. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol., 2014, 66(11), 3040-3051.
32. Kim, K. I.; Park, Y. S.; Im, G. I. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res., 2013, 28(5), 1050-1060.
33. Cheung, K.S.; Hashimoto, K.; Yamada, N.; Roach, H. I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA demethylation. Rheumatol. Int., 2009, 29(5), 525-534.
34. de Andres, M.C.; Imagawa, K.; Hashimoto, K.; Gonzalez, A.; Roach, H.I.; Goldring, M.B.; Oreffo, R.O. Loss of methylation in CpG sites in the NF-kappaB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum., 2013, 65(3), 732-742.
35. Loeser, R.F.; Im, H.J.; Richardson, B.; Lu, Q.; Chubinskaya, S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis. Cartilage, 2009, 17(4), 513-517.
36. Fernandez-Tajes, J.; Soto-Hermida, A.; Vazquez-Mosquera, M.E.; Cortes-Pereira, E.; Mosquera, A.; Fernandez-Moreno, M.; Oreiro, N.; Fernandez-Lopez, C.; Fernandez, J.L.; Rego-Perez, I.; Blanco, F.J. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann. Rheum. Dis., 2014, 73(4), 668-677.
37. Rushton, M.D.; Reynard, L.N.; Barter, M.J.; Refaie, R.; Rankin, K. S.; Young, D.A.; Loughlin, J. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol., 2014, 66(9), 2450-60.
38. den Hollander, W.; Ramos, Y.F.; Bos, S.D.; Bomer, N.; van der Breggen, R.; Lakenberg, N.; de Dijcker, W.J.; Duijnisveld, B.J.; Slagboom, P.E.; Nelissen, R.G.; Meulenbelt, I. Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Ann. Rheum. Dis., 2014, 73(12), 2208-2212.
39. Jeffries, M.A.; Donica, M.; Baker, L.; Stevenson, M.; Annan, A.C.; Humphrey, M.B.; James, J.A.; Sawalha, A.H. Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol., 2014, 66(10), 2804-15.
40. Moazedi-Fuerst, F.C.; Hofner, M.; Gruber, G.; Weinhaeusel, A.; Stradner, M.H.; Angerer, H.; Peischler, D.; Lohberger, B.; Glehr, M.; Leithner, A.; Sonntagbauer, M.; Graninger, W.B. Epigenetic differences in human cartilage between mild and severe OA. J. Orthop. Res., 2014, 32(12), 1636-1645.
41. Reynard, L. N.; Loughlin, J. The genetics and functional analysis of primary osteoarthritis susceptibility. Expert Reviews in Molecular Medicine 2013, 15, null.
42. Reynard, L.N.; Loughlin, J. Genetics and epigenetics of osteoarthritis. Maturitas, 2012, 71(3), 200-204.
43. Rakyan, V.K.; Down, T.A.; Balding, D.J.; Beck, S. Epigenomewide association studies for common human diseases. Nat. Rev. Genet., 2011, 12 (8), 529-541.
44. Meulenbelt, I.; Min, J. L.; Bos, S.; Riyazi, N.; Houwing-Duistermaat, J.J.; van der Wijk, H.-J.; Kroon, H.M.; Nakajima, M.; Ikegawa, S.; Uitterlinden, A.G.; van Meurs, J.B.J.; van der Deure, W.M.; Visser, T.J.; Seymour, A.B.; Lakenberg, N.; van der Breggen, R.; Kremer, D.; van Duijn, C.M.; Kloppenburg, M.; Loughlin, J.; Slagboom, P.E. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum. Mol. Genet., 2008, 17 (12), 1867-1875.
45. Bos, S. D.; Bovee, J.V.M.G.; Duijnisveld, B.J.; Raine, E.V.A.; van Dalen, W. J.; Ramos, Y. F. M.; van der Breggen, R.; Nelissen, R. G. H. H.; Slagboom, P.E.; Loughlin, J.; Meulenbelt, I. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann. Rheum. Dis., 2012, 71(7), 1254-1258.
46. Southam, L.; Rodriguez-Lopez, J.; Wilkins, J.M.; Pombo-Suarez, M.; Snelling, S.; Gomez-Reino, J.J.; Chapman, K.; Gonzalez, A.; Loughlin, J. An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet., 2007, 16(18), 2226-2232.
47. Chapman, K.; Takahashi, A.; Meulenbelt, I.; Watson, C.; Rodriguez-Lopez, J.; Egli, R.; Tsezou, A.; Malizos, K.N.; Kloppenburg, M.; Shi, D.; Southam, L.; van der, B. R.; Donn, R.; Qin, J.; Doherty, M.; Slagboom, P.E.; Wallis, G.; Kamatani, N.; Jiang, Q.; Gonzalez, A.; Loughlin, J.; Ikegawa, S. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet., 2008, 17(10), 1497-1504.
48. Valdes, A.M.; Evangelou, E.; Kerkhof, H.J.; Tamm, A.; Doherty, S. A.; Kisand, K.; Tamm, A.; Kerna, I.; Uitterlinden, A.; Hofman, A.; Rivadeneira, F.; Cooper, C.; Dennison, E. M.; Zhang, W.; Muir, K. R.; Ioannidis, J.P.; Wheeler, M.; Maciewicz, R.A.; van Meurs, J.B.; Arden, N.K.; Spector, T.D.; Doherty, M. The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann. Rheum. Dis., 2011, 70(5), 873-875.
49. Egli, R.J.; Southam, L.; Wilkins, J.M.; Lorenzen, I.; Pombo-Suarez, M.; Gonzalez, A.; Carr, A.; Chapman, K.; Loughlin, J. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum., 2009, 60(7), 2055-2064.
50. Talens, R.P.; Christensen, K.; Putter, H.; Willemsen, G.; Christiansen, L.; Kremer, D.; Suchiman, H.E.; Slagboom, P.E.; Boomsma, D.I.; Heijmans, B.T. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell, 2012, 11(4), 694-703.
51. Klug, M.; Rehli, M. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics, 2006, 1(3), 127-130.
52. Reynard, L.N.; Bui, C.; Syddall, C.M.; Loughlin, J. CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383. Hum. Genet., 2014, 133(8), 1059-1073.
53. Zuin, J.; Dixon, J.R.; van der Reijden, M.I.; Ye, Z.; Kolovos, P.; Brouwer, R.W.; van de Corp; van de Werken, H.J.; Knoch, T.A.; van IJcken, W.F.; Grosveld, F.G.; Ren, B.; Wendt, K.S. Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells. Proc. Natl. Acad. Sci. U. S. A, 2014, 111(3), 996-1001.
54. Smyk, M.; Szafranski, P.; Startek, M.; Gambin, A.; Stankiewicz, P. Chromosome conformation capture-on-chip analysis of long-range cis-interactions of the SOX9 promoter. Chromosome. Res., 2013, 21(8), 781-788.
55. Sanyal, A.; Lajoie, B. R.; Jain, G.; Dekker, J. The long-range interaction landscape of gene promoters. Nature 2012, 489(7414), 109-113.
56. den Hollander, W.; Ramos, Y.F.M.; Bomer, N.; Elzinga, S.; van der Breggen, R.; Lakenberg, N.; de Dijcker, W.J.; Suchiman, E.D.; Duijnisveld, B.J.; Houwing-Duistermaat, J.J.; Slagboom, E.P.; Bos, S.D.; Nelissen, R.G.H.H.; Meulenbelt, I. Transcriptional associations of osteoarthritis mediated loss of epigenetic control in articular cartilage. Arthritis Rheumatol.,2015, 67(8), 2108-16.
57. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet, 2012, 380 (9844), 815-823.
58. Rushton, M.D.; Young, D.A.; Loughlin, J.; Reynard, L.N. Differential DNA methylation and expression of inflammatory and zinc transporter genes defines subgroups of osteoarthritic hip patients. Ann. Rheum. Dis., 2015, 74(9),1778-82
59. Herrero-Beaumont, G.; Roman-Blas, J. A.; Castaneda, S.; Jimenez, S. A. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin. Arthritis Rheum., 2009, 39 (2), 71-80.
60. Ramos, Y.F.; Bos, S.D.; Lakenberg, N.; Bohringer, S.; den Hollander, W. J.; Kloppenburg, M.; Slagboom, P. E.; Meulenbelt, I. Genes expressed in blood link osteoarthritis with apoptotic pathways. Ann. Rheum. Dis., 2014, 73(10), 1844-1853.
61. Loughlin, J.; Reynard, L.N. Osteoarthritis: Epigenetics of articular cartilage in knee and hip OA. Nat. Rev. Rheumatol. 2015, 11(1), 6-7.
62. Meulenbelt, I.; Kloppenburg, M.; Kroon, H.M.; Houwing-Duistermaat, J.J.; Garnero, P.; Hellio Le Graverand, M. P.; Degroot, J.; Slagboom, P. E. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann. Rheum. Dis., 2006, 65(3), 360-365.
63. Meulenbelt, I.; Kloppenburg, M.; Kroon, H.M.; Houwing-Duistermaat, J.J.; Garnero, P.; Hellio-Le Graverand, M.P.; Degroot, J.; Slagboom, P.E. Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthritis. Cartilage, 2007, 15(4), 379-385.
64. Van Spil, W.E.; Jansen, N.W.; Bijlsma, J.W.; Reijman, M.; Degroot, J.; Welsing, P.M.; Lafeber, F.P. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis. Cartilage, 2012, 20(7), 745-754.
65. Ramos, Y.F.; Hollander, W.D.; Lakenberg, N.; van der Breggen, R.; Bomer, N.; Kroon, H.; Kloppenburg, M.; Slagboom, P.; Meulenbelt, I. Risk prediction using epigenetic profiles in blood of osteoarthritis patients. Osteoarthritis Cartilage, 2015, 23 Supplement 2(0), A73-A74.
66. Karouzakis, E.; Trenkmann, M.; Gay, R.E.; Michel, B.A.; Gay, S.; Neidhart, M. Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts. J. Immunol., 2014, 193(10), 4945-4951.
67. Nakano, K.; Boyle, D.L.; Firestein, G.S. Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol., 2013, 190(3), 1297-1303.
68. Park, S.H.; Kim, S.K.; Choe, J.Y.; Moon, Y.; An, S.; Park, M.J.; Kim, D.S. Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. Mol. Cells, 2013, 35 (4), 298-304.
69. Zhang, Y.; Fukui, N.; Yahata, M.; Lee, M. Genome-wide DNA methylation profiling of osteoarthritic subchondral bone. Osteoarthritis Cartilage, 2015, 23 Supplement 2(0), A195.